We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make u... Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit. Show more
Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024. Kristin Peck, Chief Executive Officer, will represent the company and respond to...
Prestigious honor recognizes Zoetis as a leading U.S. company for workplace fairness in talent strategies, workplace and supplier diversity practices and philanthropic engagement Zoetis also...
Reports Revenue of $2.2 Billion, Growing 10%, and Net Income of $599 Million, or $1.31 per Diluted Share, Increasing 9% and 10%, Respectively, on a Reported Basis for First Quarter 2024 Delivers...
Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetisโ...
As we celebrate World Veterinary Day, the Zoetis Foundation is proud to support veterinarians around the world today and everyday by providing grant support to initiatives promoting veterinary...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 7.92 | 4.77712769166 | 165.79 | 174.99 | 164.92 | 2183478 | 169.61335935 | CS |
4 | 21.81 | 14.3581303489 | 151.9 | 174.99 | 144.8 | 3795714 | 159.00956962 | CS |
12 | -15.32 | -8.1045336719 | 189.03 | 200.5341 | 144.8 | 3781483 | 167.30833079 | CS |
26 | -1.32 | -0.754156430326 | 175.03 | 201.92 | 144.8 | 2787855 | 175.25894703 | CS |
52 | -9.16 | -5.00902280308 | 182.87 | 201.92 | 144.8 | 2361181 | 174.75701067 | CS |
156 | 1.46 | 0.847605224964 | 172.25 | 249.27 | 124.1483 | 2086929 | 177.30127721 | CS |
260 | 71.31 | 69.638671875 | 102.4 | 249.27 | 90.14 | 2056035 | 161.58482963 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions